Physicians Update
Our quarterly newsletter provides you with relevant educational and timely news affecting laboratory medicine.
Documents below are in PDF Format. If you do not have Acrobat Reader, you may download the latest version from Adobe's site.< Back to Healthcare Professionals | Newsletters
Volume XXIV, No. 3.Featured in this Issue:
- A discussion of ePrescribing
- Some thoughts and considerations about implementing an EHR for your practice
Featured in this Issue:
- A1C likely to be recommended as a screening test for diabetes
- HPV 16/18 genotyping now an option for follow-up of NILM Pap test with positive high-risk HPV DNA
- Novel Strain of 2009 H1N1 Influenza Virus preparedness. What you need to know!
Featured in this Issue:
- Editor's note: Quest Diagnostics named to FORTUNE magazine's Most Admired list for second consecutive year
- CKD Revisited
- Prediabetes Consensus Statement
- Iatrogenic Hyperkalemia
Featured in this Issue:
- A discussion of the use of high sensitivity CRP for risk evaluation in patients without hyperlipidemia with emphasis on the Jupiter trial
- Update from the CDC on identification of persons with chronic hepatitis B virus infection
Featured in this Issue:
- A discussion of the three phases of laboratory testing and their contribution to spurious test results
- An update to the factors which can cause pseudohyperkalemia
- American Academy of Pediatrics issues report on cardiovascular health in childhood
Featured in this Issue:
- ADA Consensus Panel issues recommendation — “Managing Preexisting Diabetes for Pregnancy”
- An Update on the laboratory diagnosis and treatment strategies for Helicobacter pylori infection
- Quest Diagnostics and Google collaborate on allowing patients to view their laboratory results in their Google Health Account
Featured in this Issue:
- A short note on how to use laboratory tests
- Quest Diagnostics makes Fortune magazine's list of Most Admired Companies
- Why measuring glycemic excursions is an important part of diabetes management
- A brief discussion of the 2006 ASCCP Consensus Guidelines on the use of high-risk HPV DNA for cervical cancer screening
Featured in this Issue:
< Back to Healthcare Professionals | Newsletters